Close Menu

NEW YORK (GenomeWeb) – Novigenix has signed a commercialization agreement with Dr Risch Medical Laboratory to distribute its PCR-based Colox blood test for early detection of colorectal cancer, giving the firm access to the Swiss German market and Lichtenstein.

The agreement comes after a similar one with Unilabs to target the French Swiss market and is part of the firm's overall European expansion plans.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.